The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis.

Saved in:
Bibliographic Details
Title: The efficiency and safety of trastuzumab and lapatinib added to neoadjuvant chemotherapy in Her2-positive breast cancer patients: a randomized meta-analysis.
Authors: Zhe-Ling Chen1, Yan-Wei Shen1, Shu-Ting Li1, Chun-Li Li1, Ling-Xiao Zhang1, Jiao Yang1, Meng Lv1, Ya-Yun Lin1, Xin Wang1, Jin Yang1 1473106133@qq.com
Source: OncoTargets & Therapy. May2016, Vol. 9, p3233-3247. 15p.
Database: Academic Search Ultimate
Description
ISSN:11786930
DOI:10.2147/OTT.S106055